Transcranial direct current stimulation (tDCS) may not significantly improve thinking skills in people with multiple sclerosis (MS).
The review looked at nine studies involving 274 people with MS, mostly women. It found that tDCS, a treatment that uses a small electrical current on the head, showed mixed results for improving thinking abilities. While some studies suggested it might help a little, many did not find any clear benefits. This means that tDCS might not be a reliable treatment for cognitive issues in MS right now. More research is needed to understand how tDCS could work better for people with MS.
People with MS should care about this because cognitive challenges can make daily tasks harder, like remembering things or focusing. If tDCS could help, it would be like finding a new tool to make those tasks easier. Caregivers might also benefit from knowing about these treatments, as they support their loved ones in daily activities. Healthcare providers can use this information to guide their patients in managing cognitive symptoms. Overall, understanding the effectiveness of tDCS can help everyone involved in MS care make informed decisions.
This review has some limitations, as it only included a small number of studies, which means the findings might not apply to everyone with MS. Additionally, the studies varied a lot in how they were set up, which makes it hard to draw clear conclusions. It’s important for patients and caregivers to remember that more research is needed before tDCS can be considered a reliable treatment for cognitive issues in MS.
12/1/2025
Learn how anti-NMDAR encephalitis overlaps with MS and what it means for treatment and symptom manag
Read More12/1/2025
Learn how the PHH-1V booster shot could provide better COVID protection for MS patients and their ca
Read More12/1/2025
Discover how dignity affects family caregivers of MS patients and why their feelings matter for bett
Read More12/1/2025
Learn how studying certain viral genes in our DNA may lead to better MS treatments and improve sympt
Read More12/1/2025
Discover how gut bacteria may boost cognitive function in MS patients and why gut health matters for
Read More12/1/2025
Discover how targeting Piezo1 in immune cells could change MS management and improve symptoms for pa
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Applied neuropsychology. Adult often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.